SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-086367
Filing Date
2016-03-07
Accepted
2016-03-07 16:11:29
Documents
5
Period of Report
2016-04-28
Effectiveness Date
2016-03-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A v433382_def14a.htm DEF 14A 803646
2 GRAPHIC v433382_proxycard-1.jpg GRAPHIC 997737
3 GRAPHIC v433382_proxycard-2.jpg GRAPHIC 339753
4 GRAPHIC line.gif GRAPHIC 43
5 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-16-086367.txt   2647023
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-10113 | Film No.: 161488569
SIC: 2834 Pharmaceutical Preparations